Who is a Candidate for an Axumin® PET/CT Scan?
Men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following prostatectomy or radiation therapy.
What is an Axumin® study?
- Axumin® is an FDA approved imaging agent, also known as a "tracer", which helps a physician determine if and where your prostate cancer has recurred.
- Axumin® includes a radioactive element (F 18) used to produce images.
- The study is performed on a PET/CT scanner at a RadNet outpatient imaging facility.
- The total exam is approximately 30-40 minutes.
Axumin® performed at the following locations:
NORTHERN CALIFORNIA
NorCal Imaging Walnut Creek
114 La Casa Via Walnut Creek, CA 94598
NEW JERSEY
New Jersey Imaging Network – Union
445 Chestnut St, Union, NJ 07083
NEW YORK
Lenox Hill Radiology
400 E 66th St, New York, NY 10065
Hudson Valley Radiology Associates
111 North Highland Ave. Nyack, NY 10960
MARYLAND
Advanced Radiology Harford Imaging
201 Plumtree Rd Ste. 101 Bel Air, MD 21015
SOUTHERN CALIFORNIA
Liberty Pacific Advanced Imaging
18133 Ventura Blvd. Suite 100, Tarzana, CA 91356
Beverly Tower Wilshire
8750 Wilshire Blvd. Beverly Hills, CA 90211
Orange Advanced Imaging
230 S. Main Street Orange, CA 92868
Temecula Valley Advanced Imaging
25455 Medical Center Dr. Suite 100 Murietta, CA 92562
Imaging Specialists of Pasadena
630 South Raymond Ave. Suite 210 Pasadena, CA 91105
Rolling Oaks Radiology
415 Rolling Oaks Dr. Suite 125 Thousand Oaks, CA 91361